Oncolife Highlights Rarecells in Salute Europa Interview with Founder Dr. Patrizia Paterlini, MD, PhD
Rarecells Announces New Clinical Data Showing Superior Sensitivity and Tumor Heterogeneity Detection by Synergistic Combination of ctDNA and ISET® CTC-DNA in Patients with Early-Stage Lung Cancer
Vanity Fair Italy Interviews Rarecells Founder Dr. Patrizia Paterlini
Rarecells, Inc. Appoints Dr. Rita Shaknovich to Scientific Advisory Board
Press Release: Rarecells, Inc. Appoints Dr. Neil Kurtz to Board of Directors
Press Release: Rarecells announces Appointment of New Director to the Board